Alzamend Neuro, Inc. Common Stock (ALZN) is a publicly traded Healthcare sector company. As of May 21, 2026, ALZN trades at $1.29 with a market cap of $3.88M and a P/E ratio of -0.09. ALZN moved +23.76% today. Year to date, ALZN is -41.46%; over the trailing twelve months it is -65.91%. Its 52-week range spans $0.84 to $17.10. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces ALZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alzamend Neuro, Inc. Common Stock (ALZN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ALZN moved +23.76% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.29 |
| Market Cap | $3.88M |
| P/E Ratio | -0.09 |
| EPS | $-11.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.10 |
| 52-Week Low | $0.84 |
| Volume | 75.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $4.50M |
| Gross Margin | 0.00% |
1 analysts cover ALZN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.